Skip to content
Open access

Single‐cell atlas of neuroglial dynamics in SNCA‐A53T Parkinson's disease mouse model

Jul 2026 · Animal Models and Experimental Medicine · Vol 9, pp. 1613 - 1632 · 0 citations · 46 references
Medicine

TL;DR

This data indicates that suppression of dopaminergic neurons in the substantia nigra results in striatal dopamine depletion and motor dysfunction in Parkinson's disease, and further studies are needed to establish a specific mechanism behind this phenomenon.

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive degeneration of midbrain substantia nigra dopaminergic neurons, resulting in striatal dopamine depletion and motor dysfunction. While this pathological cascade is well‐established, its underlying mechanisms remain elusive.

Read PDF

Similar papers

Open access Aug 2026

Regional astrocyte dysregulation and altered glymphatic‐related markers in Alzheimer's disease frontal cortex

Astrocyte dysfunction is central to Alzheimer's disease (AD), yet expression patterns of astrocytic markers remain poorly defined. We measured Aquaporin‐4 (AQP4) and glial fibrillary acidic protein (GFAP) in post‐mortem frontal cortex of AD patients and controls across BrainNet Europe (BNE) stages.

Harry Alexopoulos, X. Louka, E. D. de Natale et al. · 0 citations
Editorial Open access Aug 2026

Data-driven neuropathology modelling of neurodegenerative disorders: how to implement AI?

This scientific commentary refers to ‘Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes’ by Cullinane et al. (https://doi.org/10.1093/brain/awag131).

D. Thal, J. Schaeverbeke · 0 citations
Open access Aug 2026

miR155, triplicated in Down syndrome, regulates the development of neural stem cells and GABAergic interneurons in Alzheimer's disease mouse and human iPSC models

Dysfunctional microRNAs and GABAergic interneurons are features of Alzheimer's disease (AD). The role of neuronal microRNA155 (miR155), elevated in both AD and Down syndrome (DS), remains unknown.

Xiao-Dong Zhu, Jean-Vianney Haure-Mirande, Mesude Bicak et al. · 0 citations
Open access Aug 2026

Inhibition of Moesin and CD44 in stem cell‐derived neurons affects the pathological genetic signature associated with Alzheimer's disease

Using human induced pluripotent stem cells (hiPSCs)‐derived neurons, human induced pluripotent stem cells were assayed how reducing gene expression of MSN and CD44 affected amyloid beta secretion, tau phosphorylation, and transcriptional state.

Eiden H. Brewer, Charles A. Williams, Gregory A. Cary et al. · 0 citations